Third Harmonic Bio, Inc. (THRD) — Financial statements
Income statement, balance sheet, and cash flow for Third Harmonic Bio, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cost of Revenue | 0.00↓100.0% | 0.04↓7.9% | 0.04 | 0.00 | 0.00 | |
| Gross Profit | -0.05↓40.0% | -0.04↑7.9% | -0.04 | 0.00 | 0.00 | |
| Operating Expenses | ||||||
| R&D Expenses | 37↑52.3% | 24↓1.8% | 24↑55.0% | 16↑58.2% | 10 | |
| General & Administrative Expenses | 22↑11.9% | 20↑50.3% | 13↑308.5% | 3↑179.0% | 1 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 22↑11.9% | 20↑50.3% | 13↑308.5% | 3↑179.0% | 1 | |
| Other Expenses | 0.00↑100.0% | -0.04 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 59↑34.0% | 44↑16.5% | 38↑98.4% | 19↑70.9% | 11 | |
| Total Costs & Expenses | -59↓233.9% | 44↑16.6% | 38↑98.4% | 19↑70.9% | 11 | |
| Operating Results | ||||||
| Operating Income | 59↑233.9% | -44↓16.6% | -38↓98.4% | -19↓70.9% | -11 | |
| Depreciation & Amortization | 0.05↑40.0% | 0.04↓7.9% | 0.04↓99.8% | 19↑70.9% | 11 | |
| EBITDA | -45↓47.5% | -31↑12.3% | -35↓231.1% | -11↓528.3% | -2 | |
| EBIT | -45↓47.5% | -31↑12.3% | -35↓18.7% | -30↓131.2% | -13 | |
| Interest & Other Income | ||||||
| Net Interest Income | 13↑2.1% | 13↑614.8% | -3↓51108.9% | 0.01 | 0.00 | |
| Interest Income | 13↑2.1% | 13↑514196.9% | 0.00↑50960.0% | 0.00 | 0.00 | |
| Interest Expense | 0.00 | 0.00↓100.0% | 3 | 0.00 | 0.00 | |
| Non-Operating Income | 118↑996.8% | -13↓414.3% | -3↓124.1% | 11↑528.3% | 2 | |
| Other Income / Expenses | -13↓202.1% | 13↑414.3% | 3↑124.1% | -11↓527.9% | -2 | |
| Income Before Tax | 45↑247.5% | -31↑12.3% | -35↓18.7% | -30↓131.2% | -13 | |
| Income Tax Expense | 0.00 | 0.00↓100.0% | 3 | 0.00↑100.0% | -0.00 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 45↑247.5% | -31↑18.3% | -38↓27.4% | -30↓131.2% | -13 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 45↑247.5% | -31↑18.3% | -38↓27.4% | -30↓131.2% | -13 | |
| Bottom-Line Net Income | 45↑247.5% | -31↑12.3% | -35↓18.7% | -30↓131.2% | -13 | |
| EPS (Basic) | 1.09↑239.7% | -0.78↑12.4% | -0.89↓15.6% | -0.77↓133.3% | -0.33 | |
| EPS (Diluted) | 1.09↑239.7% | -0.78↑12.4% | -0.89↓15.6% | -0.77↓133.3% | -0.33 | |
| Weighted Average Shares | 42↑5.3% | 40↑0.7% | 39↑1.8% | 39↑0.0% | 39 | |
| Weighted Average Diluted Shares | 42↑5.3% | 40↑0.7% | 39↑1.8% | 39↑0.0% | 39 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.